Kevin F. McLaughlin

Chief Executive Officer, PRAECIS PHARMACEUTICALS INC.

Companies

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

As of each latest filing. The line shows shares held over time.

Recent filings

  • Aug 12, 2026Sold 7,000 shares at $44.53 of Vericel5
  • Aug 12, 2026Exercised options 7,000 shares at $13.05 of Vericel5
  • May 13, 2026Sold 3,500 shares at $32.82 of Vericel9
  • May 13, 2026Exercised options 3,500 shares at $13.05 of Vericel9
  • May 13, 2026Sold 3,500 shares at $32.83 of Vericel9
  • May 13, 2026Exercised options 3,500 shares at $2.63 of Vericel9
  • Apr 29, 2026Exercised options 3,200 shares of Vericel10
  • Feb 11, 2026Sold 7,000 shares at $34.66 of Vericel11
  • Feb 11, 2026Exercised options 7,000 shares at $2.63 of Vericel11
  • Nov 19, 2025Bought 50,000 shares at $2.50 of Invivyd, Inc.6
  • Nov 10, 2025Sold 7,000 shares at $38.59 of Vericel12
  • Nov 10, 2025Exercised options 7,000 shares at $2.63 of Vericel12
  • Aug 6, 2025Sold 7,000 shares at $35.92 of Vericel13
  • Aug 6, 2025Exercised options 7,000 shares at $2.76 of Vericel13
  • May 7, 2025Sold 7,000 shares at $39.98 of Vericel14
  • May 7, 2025Exercised options 7,000 shares at $2.76 of Vericel14
  • Apr 30, 2025Exercised options 3,200 shares of Vericel15
  • Feb 12, 2025Sold 1,000 shares at $55.43 of Vericel16
  • Feb 12, 2025Exercised options 1,000 shares at $2.76 of Vericel16
  • Feb 12, 2025Sold 6,000 shares at $55.47 of Vericel16
  • Feb 12, 2025Exercised options 6,000 shares at $3.74 of Vericel16
  • Nov 13, 2024Sold 7,000 shares at $55.54 of Vericel17
  • Nov 13, 2024Exercised options 7,000 shares at $3.74 of Vericel17
  • Aug 7, 2024Sold 2,000 shares at $45.99 of Vericel18
  • Aug 7, 2024Exercised options 2,000 shares at $3.74 of Vericel18